118 related articles for article (PubMed ID: 2296230)
21. Code of fair practices in the promotion of drug products.
Md State Med J; 1967 Dec; 16(12):139-40. PubMed ID: 6079133
[No Abstract] [Full Text] [Related]
22. US drug industry's guidelines on advertising too limited, say critics.
Burton B
BMJ; 2005 Aug; 331(7514):420. PubMed ID: 16110059
[No Abstract] [Full Text] [Related]
23. PAAB: a lesson in self-government.
Lexchin J
CMAJ; 1991 Apr; 144(7):844-5. PubMed ID: 2007233
[No Abstract] [Full Text] [Related]
24. Drug marketing practices criticized.
Wagner L
Mod Healthc; 1990 Dec; 20(50):12. PubMed ID: 10108088
[No Abstract] [Full Text] [Related]
25. "Ethical" drugs.
Rivin AU
Pharos Alpha Omega Alpha Honor Med Soc; 1980; 43(2):9-10. PubMed ID: 7384207
[No Abstract] [Full Text] [Related]
26. Capitol Hill panelists want FDA intervention in DTC drug advertising.
Med Health; 2005 Oct; 59(36):1, 6, 8. PubMed ID: 16238177
[No Abstract] [Full Text] [Related]
27. Drug firms vow to tone down consumer advertisements.
Wadman M
Nat Med; 2005 Sep; 11(9):910. PubMed ID: 16145559
[No Abstract] [Full Text] [Related]
28. Misrepresenting an ASHP practice standard for commercial purposes.
Myers CE
Am J Hosp Pharm; 1994 Sep; 51(17):2107-8. PubMed ID: 7985684
[No Abstract] [Full Text] [Related]
29. Voluntary control of drug promotion in Sweden.
Perman E
N Engl J Med; 1990 Aug; 323(9):616-7. PubMed ID: 2381456
[No Abstract] [Full Text] [Related]
30. Traveling medicine shows: a modern update?
Carroll-Johnson RM
Oncol Nurs Forum; 1992 Oct; 19(9):1315. PubMed ID: 1437666
[No Abstract] [Full Text] [Related]
31. Ethics in pharmaceutical advertising.
Lober CW
Dermatol Clin; 1993 Apr; 11(2):285-8. PubMed ID: 8477540
[TBL] [Abstract][Full Text] [Related]
32. Pharmaceutical promotion.
Bell KD
Med J Aust; 1990 Apr; 152(7):385-6. PubMed ID: 2102687
[No Abstract] [Full Text] [Related]
33. New DTC guidelines please drug companies, anger critics.
Med Health; 2005 Aug; 59(27):5-6. PubMed ID: 16111080
[No Abstract] [Full Text] [Related]
34. Rules of conduct and the pharmaceutical industry.
Collier J
Lancet; 1984 Feb; 1(8374):453. PubMed ID: 6142179
[No Abstract] [Full Text] [Related]
35. Questions timing of publicity on new drug.
Dorsey M
J Am Vet Med Assoc; 1999 Mar; 214(5):623-4. PubMed ID: 10088006
[No Abstract] [Full Text] [Related]
36. Drug promotion: stealth, wealth, and safety.
Lancet; 1993 Jun; 341(8859):1507-8. PubMed ID: 8099382
[No Abstract] [Full Text] [Related]
37. Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal.
Lexchin J; Holbrook A
CMAJ; 1994 Jul; 151(1):47-54. PubMed ID: 8004560
[TBL] [Abstract][Full Text] [Related]
38. Voluntary self-regulatory codes: what should we expect?
Lexchin J
Am J Bioeth; 2003; 3(3):49-50. PubMed ID: 14594491
[No Abstract] [Full Text] [Related]
39. The advertising of pharmaceutical preparations.
WHO Chron; 1969 Jun; 23(6):282-5. PubMed ID: 5793989
[No Abstract] [Full Text] [Related]
40. AAFP supports improvement, not ban, on direct-to-consumer prescription drug ads.
Kellerman R;
Ann Fam Med; 2007; 5(2):180-1. PubMed ID: 17389544
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
